Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,349 | 870 | 99.6% |
| Education | $49.66 | 9 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,041 | 120 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,661 | 132 | $0 (2024) |
| Lilly USA, LLC | $1,395 | 93 | $0 (2024) |
| PFIZER INC. | $1,331 | 111 | $0 (2024) |
| Novo Nordisk Inc | $662.43 | 47 | $0 (2024) |
| Allergan, Inc. | $649.21 | 66 | $0 (2020) |
| Amgen Inc. | $516.43 | 35 | $0 (2024) |
| Abbott Laboratories | $511.99 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $496.43 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $384.21 | 29 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,920 | 109 | AstraZeneca Pharmaceuticals LP ($369.12) |
| 2023 | $1,441 | 84 | Lilly USA, LLC ($383.13) |
| 2022 | $1,429 | 90 | Boehringer Ingelheim Pharmaceuticals, Inc. ($387.23) |
| 2021 | $1,841 | 134 | Boehringer Ingelheim Pharmaceuticals, Inc. ($384.66) |
| 2020 | $1,144 | 85 | AstraZeneca Pharmaceuticals LP ($227.57) |
| 2019 | $1,710 | 138 | AstraZeneca Pharmaceuticals LP ($263.69) |
| 2018 | $1,249 | 102 | Boehringer Ingelheim Pharmaceuticals, Inc. ($258.95) |
| 2017 | $1,664 | 137 | AstraZeneca Pharmaceuticals LP ($314.25) |
All Payment Transactions
879 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Diabetes Care | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $1.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/05/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Inflammation | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.34 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Diabetes Care | ||||||
| 11/06/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Neurology | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: VACCINES | ||||||
| 10/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: PAIN | ||||||
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/07/2024 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Diabetes Care | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: VACCINE | ||||||
| 10/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,378 | 1,846 | $224,232 | $71,848 |
| 2022 | 25 | 1,439 | 1,871 | $200,832 | $69,136 |
| 2021 | 24 | 1,470 | 1,910 | $167,675 | $71,275 |
| 2020 | 27 | 1,574 | 2,034 | $172,788 | $62,671 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 388 | $102,223 | $31,077 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 115 | 115 | $31,050 | $13,845 | 44.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 86 | $30,542 | $9,791 | 32.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 45 | 45 | $3,844 | $3,404 | 88.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 101 | 113 | $9,085 | $1,860 | 20.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 124 | 212 | $3,053 | $1,781 | 58.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 111 | 146 | $7,358 | $1,511 | 20.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 101 | 106 | $6,869 | $1,391 | 20.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 45 | 45 | $1,478 | $1,344 | 90.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 100 | 123 | $4,576 | $936.03 | 20.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 58 | 75 | $3,510 | $714.00 | 20.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 68 | 74 | $3,197 | $654.16 | 20.5% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 32 | 32 | $2,842 | $605.44 | 21.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 18 | 18 | $2,570 | $522.18 | 20.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 11 | $1,910 | $469.56 | 24.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 61 | 70 | $1,092 | $217.70 | 19.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 12 | 12 | $1,066 | $216.24 | 20.3% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 15 | $981.45 | $210.21 | 21.4% |
| 83735 | Magnesium level | Office | 2023 | 26 | 31 | $1,004 | $203.67 | 20.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 13 | 13 | $951.60 | $192.14 | 20.2% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 12 | 12 | $1,512 | $187.20 | 12.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 17 | 21 | $856.80 | $174.09 | 20.3% |
| 82746 | Folic acid level, serum | Office | 2023 | 12 | 12 | $849.60 | $172.92 | 20.4% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 23 | 29 | $800.40 | $164.14 | 20.5% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 24 | 29 | $730.80 | $147.32 | 20.2% |
About Dr. Pranav Rana, MD
Dr. Pranav Rana, MD is a Internal Medicine healthcare provider based in Springfield, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508886060.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pranav Rana, MD has received a total of $12,398 in payments from pharmaceutical and medical device companies, with $1,920 received in 2024. These payments were reported across 879 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($12,349).
As a Medicare-enrolled provider, Rana has provided services to 5,861 Medicare beneficiaries, totaling 7,661 services with total Medicare billing of $274,930. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Springfield, MO
- Active Since 07/20/2006
- Last Updated 12/27/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508886060
Products in Payments
- JARDIANCE (Drug) $1,316
- FARXIGA (Drug) $1,126
- ELIQUIS (Drug) $676.38
- TRULICITY (Drug) $608.83
- CHANTIX (Drug) $507.56
- FREESTYLE LIBRE (Device) $477.69
- MOUNJARO (Drug) $428.21
- BEVESPI AEROSPHERE (Drug) $357.51
- SPIRIVA RESPIMAT (Drug) $331.23
- SHINGRIX (Biological) $327.60
- Livalo (Drug) $319.54
- BREZTRI (Drug) $282.18
- JANUVIA (Drug) $270.58
- Rybelsus (Drug) $254.08
- Ozempic (Drug) $243.84
- XARELTO (Drug) $236.60
- LINZESS (Drug) $204.93
- NURTEC ODT (Drug) $197.60
- AIRSUPRA (Drug) $188.06
- EVENITY (Biological) $157.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Springfield
Dr. Steven Gradney, M.d, M.D
Internal Medicine — Payments: $568,658
Dr. James Bonucchi, Do, DO
Internal Medicine — Payments: $304,681
John Flack, Md, Mph, MD, MPH
Internal Medicine — Payments: $125,897
Dr. Sudeshna Banerjee, Md, MD
Internal Medicine — Payments: $62,767
Dr. Paul Madaj, M.d, M.D
Internal Medicine — Payments: $58,030
Dr. Indrajeet Mahata, M.d, M.D
Internal Medicine — Payments: $47,372